Hypertrophic obstructive cardiomyopathy

Hypertrophic obstructive cardiomyopathy is an inherited cardiovascular disorder, most commonly caused by mutations in genes encoding cardiac sarcomere proteins The defining pathophysiologic feature is dynamic left ventricular outflow tract obstruction, frequently exacerbated by systolic anterior motion of the mitral valve, which impedes blood ejection into the systemic circulation This obstruction contributes to diastolic dysfunction, myocardial ischemia, and common clinical manifestations such ...

Hypertrophic obstructive cardiomyopathy is an inherited cardiovascular disorder, most commonly caused by mutations in genes encoding cardiac sarcomere proteins It affects pediatric and adult populations and is characterized by marked, often asymmetric myocardial hypertrophy of the left ventricle—predominantly involving the interventricular septum The defining pathophysiologic feature is dynamic left ventricular outflow tract obstruction, frequently exacerbated by systolic anterior motion of the ...

It affects pediatric and adult populations and is characterized by marked, often asymmetric myocardial hypertrophy of the left ventricle—predominantly involving the interventricular septum

It affects pediatric and adult populations and is characterized by marked, often asymmetric myocardial hypertrophy of the left ventricle—predominantly involving the interventricular septum

The defining pathophysiologic feature is dynamic left ventricular outflow tract obstruction, frequently exacerbated by systolic anterior motion of the mitral valve, which impedes blood ejection into the systemic circulation This obstruction contributes to diastolic dysfunction, myocardial ischemia, and common clinical manifestations such as exertional dyspnea, angina, presyncope, syncope, and an elevated risk of ventricular arrhythmias